Group Revenue up 17% as growth in BPD (NEXTSTELLIS® and contribution from portfolio of women's health products licenced under the exclusive
licencing agreement with TXMD 31 December 2022) and International business exceed decline in PPD (dermatology)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.05 |
Change
0.040(0.80%) |
Mkt cap ! $410.2M | |||
| Open | High | Low | Value | Volume |
| $5.02 | $5.08 | $4.97 | $1.369M | 273.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1151 | $5.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.09 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| MYX (ASX) Chart |